The global gene delivery technologies market was valued at approximately USD 5.42 billion in 2024, and is projected to record a compound annual growth rate (CAGR) of 11.1 % through 2025 to 2032, signalling a robust expansion phase for delivery platforms underpinning gene therapy, cell therapy and advanced personalised medicine. From a regional manufacturing trends perspective, North America and...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek